CollPlant Biotechnologies Reports Q1 2025 Financials
Ticker: CLGN · Form: 6-K · Filed: May 28, 2025 · CIK: 1631487
Sentiment: neutral
Topics: financial-results, 6-K, reporting
TL;DR
CollPlant dropped its Q1 2025 financials, check the balance sheet and cash flow.
AI Summary
CollPlant Biotechnologies Ltd. filed a Form 6-K on May 28, 2025, reporting its first quarter 2025 financial results and balance sheet and cash flow information. The company, incorporated in Israel, operates in the orthopedic, prosthetic, and surgical appliances sector. This filing provides an update on the company's financial performance and position as of the end of the first quarter of 2025.
Why It Matters
This filing provides investors with crucial financial data for CollPlant Biotechnologies, enabling them to assess the company's performance and financial health in the first quarter of 2025.
Risk Assessment
Risk Level: low — This is a routine financial reporting filing (6-K) and does not contain new material events or significant risk disclosures.
Key Players & Entities
- CollPlant Biotechnologies Ltd. (company) — Registrant
- May 2025 (date) — Reporting period
- 20250528 (date) — Filing date
- 001-38370 (other) — SEC File Number
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report the first quarter 2025 financial results, balance sheet, and cash flow information for CollPlant Biotechnologies Ltd.
When was this Form 6-K filed with the SEC?
This Form 6-K was filed with the SEC on May 28, 2025.
What is CollPlant Biotechnologies Ltd.'s Standard Industrial Classification (SIC) code?
CollPlant Biotechnologies Ltd.'s SIC code is 3842, which corresponds to Orthopedic, Prosthetic & Surgical Appliances & Supplies.
What is the principal executive office address for CollPlant Biotechnologies Ltd. in Israel?
The principal executive office address for CollPlant Biotechnologies Ltd. is 4 Oppenheimer St, Weizmann Science Park, Rehovot 7670104, Israel.
Does CollPlant Biotechnologies Ltd. file annual reports under Form 20-F or Form 40-F?
CollPlant Biotechnologies Ltd. files annual reports under Form 20-F, as indicated by the checkmark next to 'Form 20-F ☒' in the filing.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 28, 2025 regarding CollPlant Biotechnologies Ltd (CLGN).